TABLE 3.
Matched by age and sex |
After PSM |
|||
HR† (95% C.I.) | p value | HR† (95% C.I.) | p value | |
Group | ||||
Non-Optic neuritis | Reference | Reference | ||
Optic neuritis | 1.31 (1.00–1.72) | 0.047 | 1.40 (1.05–1.87) | 0.021 |
Age | ||||
<20 | Reference | Reference | ||
20–39 | 1.04 (0.65–1.67) | 0.862 | 1.41 (0.73–2.74) | 0.306 |
40–64 | 1.71 (1.11–2.63) | 0.015 | 2.13 (1.14–3.96) | 0.017 |
≥65 | 1.56 (0.97–2.51) | 0.069 | 1.91 (0.97–3.78) | 0.062 |
Sex | ||||
Female | Reference | Reference | ||
Male | 0.69 (0.57–0.83) | <0.001 | 0.70 (0.54–0.90) | 0.006 |
Hypertension | 1.22 (0.93–1.59) | 0.152 | 1.04 (0.72–1.51) | 0.821 |
Hyperlipidemia | 1.00 (0.68–1.47) | 0.999 | 0.70 (0.38–1.29) | 0.248 |
Chronic liver disease | 1.49 (1.01–2.19) | 0.042 | 1.73 (1.10–2.70) | 0.017 |
Chronic kidney disease | 0.86 (0.27–2.70) | 0.797 | 1.32 (0.42–4.17) | 0.637 |
Diabetes | 0.93 (0.65–1.34) | 0.712 | 1.02 (0.62–1.66) | 0.945 |
COPD | 1.37 (0.86–2.19) | 0.180 | 1.24 (0.68–2.27) | 0.477 |
Cancer | 1.06 (0.56–2.00) | 0.851 | 0.90 (0.40–2.04) | 0.803 |
Ischemic heart disease | 0.86 (0.55–1.34) | 0.507 | 0.78 (0.41–1.48) | 0.452 |
Stroke | 1.39 (0.88–2.18) | 0.157 | 1.50 (0.86–2.63) | 0.155 |
Corticosteroids | 0.78 (0.62–0.98) | 0.033 | 0.88 (0.67–1.15) | 0.360 |
†Adjusted for age, sex, hypertension, hyperlipidemia, chronic liver disease, chronic kidney disease, diabetes, COPD, cancer, ischemic heart disease, stroke, and corticosteroids. PSM, propensity score matching.